Algieac (Sodium Alginate)

Adult dose

For the hemostasis and improvement of subjective symptoms in gastric and duodenal ulcers and erosive gastritis, sodium alginate is usually administered orally in a single dose of 1–3g (approximately 20–60mL) 3–4 times a day on an empty stomach. If oral administration is not possible, it is administered via sonde. For hemostasis during gastric biopsy bleeding, a typical dose is 0.5–1.5g (approximately 10–30mL) administered endoscopically, and 1.5g (approximately 30mL) is administered orally.

This medication may occasionally cause gastrointestinal symptoms such as diarrhea or constipation during use, so if these symptoms occur, it is important to immediately stop taking it and consult a doctor or dentist. It is advisable to bring along the accompanying documents containing information about this medication during the consultation. Furthermore, caution should be taken as the therapeutic effect may decrease if this drug does not adequately transform into a gel form due to a lack of gastric acid. This drug contains caramel ingredients; therefore, patients with allergies or hypersensitivity to this component must discuss it with a healthcare professional before use.

Mild side effects

Symptoms such as diarrhea and constipation may occasionally occur.

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1°C to 30°C. This helps to preserve the medication's effectiveness for a longer time.

Appearance

A viscous solution of light brown color contained in an aluminum foil pouch.

Package unit

25mL/1 pouch x 20 pouches